X2VE3SA
Restriction Descending Thoracic Aorta and Abdominal Aorta to New Technology Group 10 with Branched Intraluminal Device, Manufactured Integrated System, Four or More Arteries, Percutaneous Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | X New Technology |
| Body System | 2 Cardiovascular System |
| Operation | V Restriction |
| Body Part | E Descending Thoracic Aorta and Abdominal Aorta |
| Approach | 3 Percutaneous |
| Device | S Branched Intraluminal Device, Manufactured Integrated System, Four or More Arteries |
| Qualifier | A New Technology Group 10 |
Operation Definition
Partially closing an orifice or the lumen of a tubular body part
Procedure Overview
This family covers procedures that narrow rather than close off a blood vessel or chamber, most notably placement of a coronary sinus reducer for patients with disabling angina that has not responded to medication, bypass surgery, or stenting, and whose coronary arteries are not amenable to further revascularization. The device is an hourglass-shaped implant delivered by catheter into the coronary sinus, the vein that drains blood from the heart muscle back to the right atrium. By creating a controlled narrowing at that point, it raises pressure in the small veins upstream, which appears to redistribute blood flow toward oxygen-starved areas of heart muscle and reduce chest pain episodes.
Patients considered for this therapy typically have exhausted standard options and continue to have frequent angina that limits daily activity. The procedure is done in a catheterization lab under fluoroscopic guidance, generally as an outpatient or short-stay procedure, and does not involve opening the chest.
Anatomy & Axis Detail
Descending Thoracic Aorta and Abdominal Aorta
This body part designation spans the aorta from below the left subclavian artery through the abdominal segment proximal to the iliac bifurcation, a long continuous conduit that can be affected by extensive dissection or aneurysmal disease crossing the diaphragm. Restriction procedures using new-technology devices in this combined region typically involve endovascular stent-graft systems designed to narrow a true lumen or seal a dissection flap across both thoracic and abdominal levels in a single staged approach. Because the segment traverses the diaphragmatic hiatus and gives rise to the celiac, mesenteric, and renal arteries, device deployment must preserve these branch origins while achieving the intended luminal narrowing. Coders should confirm from the operative report that the device genuinely spans both the descending thoracic and abdominal segments rather than one alone, since narrower body part values exist for each region separately.
Approach: Percutaneous
In New Technology, Percutaneous describes entry into the body via needle or instrument puncture through the skin or a mucous membrane, without a surgical incision, mirroring the same concept in Medical and Surgical. It is distinguished from Open access, which requires a full incision, and from Percutaneous Endoscopic, which adds visualization through the puncture site.
Device / Substance / Technology: Branched Intraluminal Device, Manufactured Integrated System, Four or More Arteries
This value specifies a branched intraluminal endograft manufactured as a single integrated system designed to accommodate four or more branch arteries, used in complex endovascular repair of thoracoabdominal or aortic arch aneurysms. It is distinguished from simpler branched devices covering fewer vessels by both the higher branch count and its pre-manufactured, integrated construction rather than a modular or physician-assembled system. This complexity allows single-stage repair of aneurysms involving multiple visceral or arch vessels.
Qualifier: New Technology Group 10
New Technology Group 10 flags a procedure as part of the 2023 batch of add-on codes recognized under the New Technology section. The value itself carries no information about the device or drug involved; that comes from the table, body part, and approach values alongside it. Coders should not confuse it with Group 9 or Group 11, which cover the cohorts approved in the years immediately before and after.
Coding & Documentation
Assignment depends on documentation identifying the coronary sinus as the treated body part and confirming that a new-technology intraluminal device was deployed, since this root operation and device combination is what distinguishes the procedure from a standard coronary intervention. The operative note should specify catheter-based delivery and device sizing/deployment, along with confirmation of correct final position by contrast venography. A common assignment error is defaulting to a generic Dilation or Occlusion code for coronary sinus work, when the reducer's mechanism is a partial, fixed narrowing rather than either widening a vessel or completely blocking it. Coders should also verify the approach value reflects percutaneous access and confirm the device is captured under the correct new-technology group rather than a conventional device value.